Overview

In the United States, nearly 100 million people are affected by liver disease. With over 100 diseases that affect the liver, our patient constituency is diverse in age, demographics, and geography.

ALF’s mission is to promote education, advocacy, support services and research for the prevention, treatment and cure of liver disease. ALF makes an impact in the fight against liver disease by educating patients, families, caregivers and healthcare professionals; advocating for patients and their families; funding medical research to advance treatments for liver patients; and creating public awareness campaigns about liver wellness and disease prevention. ALF is the trusted voice for all patients and families living with liver disease.

The Foundation works closely with leading hepatologists, transplant surgeons, physicians, and key opinion leaders in the field of liver disease to ensure clinical accuracy and provide strategic direction via ALF’s national programs such as Think Liver Think Life, health and wellness of adults and children, free programs and events, a robust online resource center, living donor liver transplant, and so many more!

Purpose of the Corporate Council

The ALF Corporate Council framework facilitates coalition building and funding partnerships that will lead to benefits for patients with liver disease, their caregivers, and other constituents. Membership in the ALF Corporate Council is by annual dues.

Representatives from pharmaceutical, biotech, health information technology, imaging, payers, wellness, fitness, and other corporations interested in and able to advance the American Liver Foundation mission are invited to join the Corporate Council. Professionals from throughout the enterprise: alliance development, advocacy, managed markets, medical affairs, research and patient engagement are all encouraged to attend meetings.